首页> 外文期刊>Journal of Medical Virology >Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapy.
【24h】

Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapy.

机译:拉米夫定治疗停药后,e抗原阴性的慢性乙型肝炎恶化之前,precore-stop突变体的出现和接管。

获取原文
获取原文并翻译 | 示例
       

摘要

Although hepatitis B virus (HBV) precore-stop mutant (nonsense mutation at codon 28) is usually isolated from patients with hepatitis B e antigen (HBeAg)-negative hepatitis, it is unclear whether the mutant is the cause of the hepatitis flare or it is a consequence of necroinflammation. Using the amplification-created restriction site method, the ratios of precore-stop mutant were measured in serial serum samples obtained from three patients experiencing HBeAg-negative hepatitis after withdrawal of lamivudine therapy. In all three patients, the precore-stop mutant emerged and took over the viral population at least 2 months prior to the hepatitis exacerbations. After the onset of exacerbation, transient elevation of serum HBV-DNA was observed, which was followed by progressive decrease of the ratio of precore-stop mutant as well as normalization of serum transaminases. The present data indicate that at least in some patients, the precore-stop mutant is the cause but not the consequence of the flare of HBeAg-negative hepatitis.
机译:尽管通常从患有乙型肝炎e抗原(HBeAg)阴性的肝炎患者中分离出乙肝病毒前核终止突变体(第28位密码子无意义突变),但尚不清楚该突变体是否是引起肝炎发作的原因是坏死性炎症的结果。使用扩增产生的限制性位点法,在拉米夫定治疗停药后,从三名患有HBeAg阴性肝炎的患者的连续血清样本中,测量了precore-stop突变体的比率。在所有三名患者中,前核心终止突变体出现并在肝炎恶化之前至少两个月接管了病毒种群。加重发作后,观察到血清HBV-DNA短暂升高,随后逐渐减少前核心终止突变体的比例以及血清转氨酶的正常化。目前的数据表明,至少在某些患者中,precore-stop突变体是HBeAg阴性肝炎爆发的原因,但不是后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号